Trial · NCT00172172
Calcium Supplementation in Postmenopausal Women
NCT00172172, Phase 3, Completed, Shire
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Calcium Supplementation in Postmenopausal Women. Trials, record NCT00172172. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00172172
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Calcium Supplementation in Postmenopausal Women
- NCT number
- NCT00172172
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 374 participants, actual
- Lead sponsor
- Shire
- Conditions
- Osteoporosis
- Interventions
- PTH/Calcium, PTH/placebo, placebo
- First posted
- 2005-09-15
- Last updated
- 2021-05-25
Source ClinicalTrials.gov
Registered outcomes18
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Evaluate subjects treated with ALX1-11 (no calcium supplementation) increase in BMD is less than those treated with ALX1-11 (receiving calcium supplementation). | 6 months | |
| Primary | Primary efficacy variable is the percentage change from baseline of lumbar vertebral BMDmeasured by DXA. | 6 months | |
| Secondary | BMC, | 6 months | |
| Secondary | vBMD, | 6 months | |
| Secondary | the incidence of clinical fractures, | 6 months | |
| Secondary | height, | 6 months | |
| Secondary | biochemical markers of bone turnover for subjects treated with ALX1-11 and receiving no calcium versus those receiving ALX1-11 with calcium supplementation. | 6 months | |
| Secondary | Adverse Events | 6 months | |
| Secondary | 12 lead ECG changes | 6 months | |
| Secondary | Percentage change from baseline of lumbar vertebral BMC | 6 months |
1 to 10 of 18Source ClinicalTrials.gov
See all 18 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00172172
GET https://conductscience.org/api/trials/v1/NCT00172172/registered